CVS Health reported an 8.3% increase in total revenues to $66.8 billion and a 28.6% increase in GAAP operating income to $3.5 billion. Adjusted EPS was $1.91, and the company generated $3.3 billion in cash flow from operations. 2020 full year EPS guidance remains unchanged.
Total revenues increased 8.3% to $66.8 billion
GAAP operating income increased 28.6% to $3.5 billion
Adjusted EPS of $1.91
Cash flow from operations of $3.3 billion
While acknowledging the inherent and unprecedented uncertainty surrounding the ongoing COVID-19 pandemic and its impact, the Company’s full year 2020 GAAP diluted EPS guidance range of $5.47 to $5.60, its full year 2020 Adjusted EPS guidance range of $7.04 to $7.17 and its full year 2020 cash flow from operations guidance range of $10.5 billion to $11.0 billion remain unchanged.Given the likelihood of significant variability in the impact of COVID-19 on its financial statement line items (and related ratios), the Company is withdrawing all other previously issued 2020 additional detailed guidance.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance